Salter RD - Search Results

1

Tn-MUC1 DC Vaccination of Rhesus Macaques and a Phase I/II Trial in Patients with Nonmetastatic Castrate-Resistant Prostate Cancer.

Scheid E, Major P, Bergeron A, Finn OJ, Salter RD, Eady R, Yassine-Diab B, Favre D, Peretz Y, Landry C, Hotte S, Mukherjee SD, Dekaban GA, Fink C, Foster PJ, Gaudet J, Gariepy J, Sekaly RP, Lacombe L, Fradet Y, Foley R. Scheid E, et al. Among authors: salter rd. Cancer Immunol Res. 2016 Oct;4(10):881-892. doi: 10.1158/2326-6066.CIR-15-0189. Epub 2016 Sep 7. Cancer Immunol Res. 2016. PMID: 27604597 Free PMC article. Clinical Trial.

2

Immunology in Pittsburgh.

Finn OJ, Salter RD. Finn OJ, et al. Among authors: salter rd. Immunol Res. 2006;36(1-3):1-2. doi: 10.1385/IR:36:1:1. Immunol Res. 2006. PMID: 17337760

3

The biosynthesis and secretion of prostate-specific antigen in LNCaP cells.

Gau JT, Salter RD, Krill D, Grove ML, Becich MJ. Gau JT, et al. Among authors: salter rd. Cancer Res. 1997 Sep 1;57(17):3830-4. Cancer Res. 1997. PMID: 9288795

4

Preventive immunization of aged and juvenile non-human primates to β-amyloid.

Kofler J, Lopresti B, Janssen C, Trichel AM, Masliah E, Finn OJ, Salter RD, Murdoch GH, Mathis CA, Wiley CA. Kofler J, et al. Among authors: salter rd. J Neuroinflammation. 2012 May 3;9:84. doi: 10.1186/1742-2094-9-84. J Neuroinflammation. 2012. PMID: 22554253 Free PMC article.

5

Flow-cytometric determination of peptide-class I complex formation. Identification of p53 peptides that bind to HLA-A2.

Zeh HJ 3rd, Leder GH, Lotze MT, Salter RD, Tector M, Stuber G, Modrow S, Storkus WJ. Zeh HJ 3rd, et al. Among authors: salter rd. Hum Immunol. 1994 Feb;39(2):79-86. doi: 10.1016/0198-8859(94)90105-8. Hum Immunol. 1994. PMID: 8175386

6

Identification of human melanoma peptides recognized by class I restricted tumor infiltrating T lymphocytes.

Storkus WJ, Zeh HJ 3rd, Maeurer MJ, Salter RD, Lotze MT. Storkus WJ, et al. Among authors: salter rd. J Immunol. 1993 Oct 1;151(7):3719-27. J Immunol. 1993. PMID: 7690811

7

Escherichia coli expressing recombinant antigen and listeriolysin O stimulate class I-restricted CD8+ T cells following uptake by human APC.

Hu PQ, Tuma-Warrino RJ, Bryan MA, Mitchell KG, Higgins DE, Watkins SC, Salter RD. Hu PQ, et al. Among authors: salter rd. J Immunol. 2004 Feb 1;172(3):1595-601. doi: 10.4049/jimmunol.172.3.1595. J Immunol. 2004. PMID: 14734740

8

Tumor escape from immune recognition: loss of HLA-A2 melanoma cell surface expression is associated with a complex rearrangement of the short arm of chromosome 6.

Maeurer MJ, Gollin SM, Storkus WJ, Swaney W, Karbach J, Martin D, Castelli C, Salter R, Knuth A, Lotze MT. Maeurer MJ, et al. Clin Cancer Res. 1996 Apr;2(4):641-52. Clin Cancer Res. 1996. PMID: 9816214

9

Immunotherapy of NOD mice with bone marrow-derived dendritic cells.

Feili-Hariri M, Dong X, Alber SM, Watkins SC, Salter RD, Morel PA. Feili-Hariri M, et al. Among authors: salter rd. Diabetes. 1999 Dec;48(12):2300-8. doi: 10.2337/diabetes.48.12.2300. Diabetes. 1999. PMID: 10580417

10

Mutant HLA-A201 heavy chains with lowered affinity for beta 2m are transported after growth at reduced temperatures.

Salter RD. Salter RD. Hum Immunol. 1992 Sep;35(1):40-9. doi: 10.1016/0198-8859(92)90093-3. Hum Immunol. 1992. PMID: 1478893

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

73 results

Search Page